EcoDrugPlus

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSEEUG00000000262
Gene Symbol: ENPP2
1 External references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSEEUG00000002497
Gene Symbol: EGLN1
1 External references
239 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSEEUG00000009984
Gene Symbol: EGLN3
1 External references
208 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSEEUG00000012802
Gene Symbol: EPAS1
1 External references
225 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSEEUG00000010851
Gene Symbol: EDNRA
1 External references
270 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSEEUG00000005720
Gene Symbol: EDNRB
1 External references
267 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSEEUG00000012984
Gene Symbol: EGFR
1 External references
287 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSEEUG00000009610
Gene Symbol: EPHX2
3 External references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSEEUG00000006658
Gene Symbol: ERBB2
1 External references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSEEUG00000013790
Gene Symbol: ERBB3
1 External references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSEEUG00000009967
Gene Symbol: ERBB4
1 External references
320 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSEEUG00000006141
Gene Symbol: ESR2
1 External references
274 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).